MetLife Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Buy |
|
|||||
|
2025
Q1 | $144K | Buy |
|
|||||
|
2024
Q4 | $205K | Sell |
|
|||||
|
2024
Q3 | $190K | Sell |
|
|||||
|
2024
Q2 | $257K | Buy |
|
|||||
|
2024
Q1 | $361K | Buy |
|
|||||
|
2023
Q4 | $367K | Sell |
|
|||||
|
2023
Q3 | $233K | Buy |
|
|||||
|
2023
Q2 | $558K | Sell |
|
|||||
|
2023
Q1 | $3.24M | Sell |
|
|||||
|
2022
Q4 | $2.57M | Hold |
|
|||||
|
2022
Q3 | $3.39M | Buy |
|
|||||
|
2022
Q2 | $2.14M | Buy |
|
|||||
|
2022
Q1 | $2.1M | Buy |
|
|||||
|
2021
Q4 | $1.17M | Buy |
|
|||||
|
2021
Q3 | $798K | Hold |
|
|||||
|
2021
Q2 | $1.53M | Hold |
|
|||||
|
2021
Q1 | $1.04M | Hold |
|
|||||
|
2020
Q4 | $1.38M | Sell |
|
|||||
|
2020
Q3 | $807K | Hold |
|
|||||
|
2020
Q2 | $874K | Buy |
|
|||||
|
2020
Q1 | $680K | Buy |
|
|||||
|
2019
Q4 | $683K | Hold |
|
|||||
|
2019
Q3 | $537K | Hold |
|
|||||
|
2019
Q2 | $565K | Buy |
|
|||||
|
2019
Q1 | $337K | Hold |
|
|||||
|
2018
Q4 | $228K | Hold |
|
|||||
|
2018
Q3 | $308K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $126K | Buy |
|